up and comers

5 emerging tech startups in Houston to keep an eye on

From personal and consumer technology to B2B companies ready to scale, here's who to watch in Houston tech. Getty Images

When it comes to Houston's tech startups, it's as diverse as Houston's population. There are software-as-a-service companies, new mobile technology, and even virtual reality startups that all call Houston home.

Here's a roundup of these Houston companies that you need to keep an eye on.

Hamper

Houston-based Hamper, which makes dry cleaning convenient, won the Rockets and BBVA Compass' LaunchPad competition. Courtesy of Hamper

Despite working most summers in his family's dry cleaning shop, Safir Ali wasn't thinking about taking over his family business. He was living his young professional life with a freshly minted degree from Texas A&M University and a corporate job. However, when he started thinking of all the modern conveniences available now — RedBox, ridesharing, delivery apps — he couldn't help but think of how antiquated dry cleaning was compared.

Ali and his brother hope to upgrade dry cleaning with their startup, Hamper. Ali describes it as "the Red Box of dry cleaning." Customers can deposit their dry cleaning in a kiosk in their office building, and it will be delivered straight to their suite. Originally, Safir thought the kiosks could be stand-alones, but it proved to be easier to partner with high-traffic office spaces, like those in the busy Galleria or over in Williams Tower.

The company has gained some traction — and even some prize money. Hamper won first place in the 2019 LaunchPad Contest, which was sponsored by the Houston Rockets and BBVA Compass. The win brought in a $10,000 prize, along with a consultation with Rockets and BBVA Compass executives and a host of other prizes.

Read more about Hamper here.

Pandata Tech

Houston-based Pandata Tech uses its machine learning technology to advance oil and gas operations. Photo courtesy of Pandata Tech

Drilling data can be muddled and hard to use, but Houston-based Pandata Tech has developed the technology to clean and automate data collection for its oil and gas clients. But Gustavo Sanchez, co-founder and CEO of the company, is looking to take his technology into other industries.

The Pandata team is now expanding to fields like defense and healthcare, which also generate hundreds of thousands of data points that need it be checked. The unique challenges of working with large drilling rigs have translated well to working with aircrafts. And the healthcare field is similar — with the Texas Medical Center, Houston's medical research centers can benefit from hastening the process of data validation.

"There's so much data, and it's so noisy, that it's hard to know whether the data can be trusted or not," Sanchez says.

Read more about Pandata Tech here.

Camppedia

Camppedia, a Houston-based startup, can help match kids to summer camps all around town. Photos courtesy of Camppedia

Probably the least fun thing about summer camp is finding and booking the summer camp. Of course, this responsibility falls on the busy adults' to-do lists. Two Houston parents, Tudor Palaghita and his sister Ana, wanted to create a solution for the overwhelming process.

"We're working parents, we're strapped on time, but we want to make sure we give our kids enriching experiences," explains Ana. "One spring, we were going through the [camp search] process, and we talked about how difficult it was. And the next spring, we said, there's something here. We feel this pain, our friends feel this pain, and no one is helping us. Why don't we solve our problem ourselves?"

And that's exactly what they did. The duo used their business and technology backgrounds — Ana has an MBA from Northwestern University and built a successful career in a major financial institution, and Tudor has his Ph.D. in aerospace engineering from Georgia Tech — to launch Camppedia.com. The site is intended to be a one-stop shop for parents looking for camps for their children.

The tool launched in March of 2019, coinciding with spring break. Currently, it offers options throughout central Houston. Parents can select camps for their children based on interests, their ZIP codes, cost or even those that offer extended hours for moms and dads with full-time jobs.

Read more about Camppedia here.

HTX Labs

VR training startup, HTX Labs, recently brought on Houston-based Solvay GBU Peroxides North America as a client. Trainees can work on a digitized version of the plant that looks as real as could be. Courtesy of HTX Labs

Virtual and augmented reality training in industrial settings is on the rise as the process and technology allows for quicker training and minimized risk. Houston-based startup HTX Labs LLC is one of the tech companies at the forefront of the VR-infused modernization of workplace training. Among its customers are the United States Air Force, Mastercard, Rackspace, and Houston-based Solvay GBU Peroxides North America, a maker of hydrogen peroxide.

At its core, the company's VR training zeroes in on the trainee, providing engaging, interactive experiences that stress "learning by doing," Scott Schneider, founder and CEO of HTX Labs, says. Training programs that have been around for decades are "designed for trainers, not necessarily for trainees," he says.

Read more about HTX Labs here.

Lodgeur

Lodgeur provides its guests with hotel luxury with room to breathe. Courtesy of Lodgeur

Travelers are usually faced with a decision to make: Privacy and homeliness of an apartment rental or style and class of a hotel room. Houston-based Lodgeur hopes to exist to have the best of both worlds. With Houston's busy business travel industry, founcer Sébastien Long knew he was starting in a good market.

"We're roughly split between leisure guests and business travelers," Long says. "They want to feel like they're staying in a home away from home."

The first guests arrived in mid-April. Long wanted to open by managing just a few properties, to make sure the company could ensure great guest experiences.

Read more about Lodgeur here.

Trending News

Building Houston

 
 

Tvardi Therapeutics Inc. has fresh funds to support its drug's advancement in clinical trials. Photo via Getty Images

A Houston-based clinical-stage biopharmaceutical company has raised millions in its latest round.

Tvardi Therapeutics Inc. closed its $74 million series B funding round led by new investors New York-based Slate Path Capital, Florida-based Palkon Capital, Denver-based ArrowMark Partners, and New York-based 683 Capital, with continued support and participation by existing investors, including Houston-based Sporos Bioventures.

"We are thrilled to move out of stealth mode and partner with this lineup of long-term institutional investors," says Imran Alibhai, CEO at Tvardi. "With this financing we are positioned to advance the clinical development of our small molecule inhibitors of STAT3 into mid-stage trials as well as grow our team."

Through Slate Path Capital's investment, Jamie McNab, partner at the firm, will join Tvardi's board of directors.

"Tvardi is the leader in the field of STAT3 biology and has compelling proof of concept clinical data," McNab says in the release. "I look forward to partnering with the management team to advance Tvardi's mission to develop a new class of breakthrough medicines for cancer, chronic inflammation, and fibrosis."

Tvardi's latest fundraise will go toward supporting the company's products in their mid-stage trials for cancer and fibrosis. According to the release, Tvardi's lead product, TTI-101, is being studied in a Phase 1 trial of patients with advanced solid tumors who have failed all lines of therapy. So far, the drug has been well-received and shown multiple durable radiographic objective responses in the cancer patients treated.

Dr. Keith Flaherty, who is a member of Tvardi's scientific advisory board and professor of medicine at Harvard Medical School, offered his support of the company.

"STAT3 is a compelling and validated target. Beyond its clinical activity, Tvardi's lead molecule, TTI-101, has demonstrated direct downregulation of STAT3 in patients," he says in the release. "As a physician, I am eager to see the potential of Tvardi's molecules in diseases of high unmet medical need where STAT3 is a key driver."

Trending News